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Ankyrins represent a protein family whose members
are associated with membrane proteins and the actin
cytoskeleton. The principal ankyrin domain structure
comprises an amino-terminal membrane-binding, a
spectrin-binding, and a regulatory domain, and can
be modulated by alternative splicing. In order to
investigate the role of ankyrin-3 in skin, we have iso-
lated three complete ankyrin-3 cDNA clones of
5.8 kb, 5.2 kb, and 2.5 kb by reverse transcription±
polymerase chain reaction of mouse skin RNA.
DNA sequencing con®rmed the isolated clones to be
splice variants of ankyrin-3. Of these, the smallest
cDNA represents a novel ankyrin named ankyrin-393.
Surprisingly, this novel ankyrin subtype lacks not
only all ankyrin repeats, but also the ®rst 75 amino
acids of the spectrin-binding domain. Immuno-
¯uorescence analysis of mouse skin showed that
ankyrin-3 is expressed in all living layers of mouse
epidermis. Here, it predominates along the basal and
lateral membranes of the basal layer in addition to
an even cytoplasmic distribution. In primary mouse
keratinocytes grown at elevated Ca2+ levels, ankyrin-
393 was localized along the plasma membrane and
throughout the cell in a Golgi-like fashion.
Depending on ®xation conditions, nuclear staining
became apparent in many cells. In agreement with
previous data, northern blotting revealed a wide-
spread distribution of the two larger ankyrin splice
variants. In contrast, the mRNA coding for ankyrin-
393 was restricted to mouse skin. Reverse transcrip-
tion±polymerase chain reaction of mouse skin RNA
strongly suggested additional ankyrin isoforms in
skin. Our data on ankyrin-393, which lacks a part of
the spectrin-binding domain that regulates the af®-
nity to spectrin, suggests a new function for this
member of the ankyrin family. Key words: ankyrin-3/
mouse/skin. J Invest Dermatol 116:216±223, 2001
A
nkyrins are regarded as a family of proteins that
provide the connection of integral membrane
proteins to the underlying spectrin-based cytoskele-
ton. Besides maintaining the structural integrity of the
cell, they are supposedly involved in the formation of
polarized membrane domains by accumulating and maintaining
distinct integral proteins to speci®c subcellular sites (Bennett, 1982).
Binding partners of ankyrin belong to the families of ion channel
and cell adhesion proteins, for example the Clÿ=HCO3ÿ anion
exchanger from erythrocytes (Bennett and Stenbuck, 1980), the
voltage-gated sodium channel from brain (Srinivasan et al. 1988),
the Na+/K+-ATPase from kidney (Koob et al, 1990), the
neurofascin/L1 NrCAM family (Davis and Bennett, 1994), and
the hyaluronic acid receptor CD44 (Lokeshwar et al, 1994).
All ankyrins share a protein structure with three independently
folded domains. The N-terminal 89±95 kDa membrane-binding
domain contains 24 tandem repeats, so-called ankyrin (ANK)
repeats, of a 33 amino acid sequence and is folded into four
subdomains of six repeats each. This domain enables ankyrin to
associate with transmembrane proteins. The ANK repeat is one of
the most common protein sequence motifs, and has been
recognized in more than 400 proteins in a highly variable number,
including cyclin-dependent kinases (CDK), transcriptional regula-
tors, cytoskeleton-associated proteins, developmental regulators,
and toxins (Sedgwick and Smerdon, 1999).
The central 62 kDa spectrin-binding domain is divided into a N-
terminal acidic region of high sequence variability and a C-terminal
basic region. This domain provides the linkage to b-spectrin (also
named fodrin), which is part of the subplasmalemmal cytoskeleton
based on spectrin spokes and actin hubs. The C-terminal 55 kDa
rod domain is supposed to regulate the activity of the two other
domains and is poorly conserved between ankyrins (De Matteis and
Morrow, 1998).
So far, three ankyrin genes have been identi®ed in mammals:
Ank1, Ank2, and Ank3. All ankyrin genes are subject to tissue-
speci®c alternative splicing, thereby modulating the af®nity to
different binding partners and conveying different functional roles
(Kordeli et al, 1998; De Matteis and Morrow, 1998).
Ankyrin-1 is expressed in erythrocytes and in a subset of spinal
cord and hippocampal neurons in large isoforms of 210 and
220 kDa (Bennett and Stenbuck, 1979; Lambert and Bennett,
1993). Two very small ankyrin-1 isoforms of 28 and 30 kDa have
been detected in muscle (Gallagher and Forget, 1998), which
contain only the C-terminal part of the regulatory domain. In
addition, a Golgi-associated isoform of 195 kDa in MDCK
(Madin±Darby canine kidney) epithelial cells has been preliminary
identi®ed by immunologics criteria (Beck et al, 1997). Ankyrin-2 is
the major ankyrin of the nervous system giving rise to two different
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splice variants: a 440 kDa isoform found in fetal unmyelinated
axons and dendrites, containing a 220 kDa insert between the
spectrin-binding and the regulatory domain, and a 220 kDa
isoform found in adult neuron cell bodies, dendrites, and glia
(Kunimoto et al, 1991; Otto et al, 1991).
The third member of the family, ankyrin-3, shows the most
widespread tissue distribution and is subjected to intense alternative
splicing, leading to numerous ankyrin-3 isoforms. Ankyrin-3 is the
predominant ankyrin of epithelia. In kidney, isoforms of 215, 200,
190, 170, 120, and 105 kDa are present (Peters et al, 1995). An
additional 190 kDa isoform was described for the kidney and lung
(Thevananther et al, 1998). In brain, two large isoforms of 270 and
480 kDa were localized to the axon initial segment and the node of
Ranvier (Kordeli et al, 1995). Both these isoforms have a brain-
speci®c insert between the spectrin-binding and the regulatory
domain. A Golgi-associated 119 kDa isoform of ankyrin-3
(ankG119) has been detected in the kidney and muscle (Devarajan
et al, 1996). Finally, two small isoforms of 100 and 120 kDa have
been found associated with lysosomes of macrophages (Hoock et al,
1997). These three small isoforms all miss part or all of the repeat
domain and in the case of ankG119 even part of the regulatory
domain.
Thus, besides the expression of multiple isoforms of the same
ankyrin gene in a cell, ankyrin isoforms of different ankyrin genes
can be expressed in the same cell with distinct localizations
indicating related but distrinct functions: in the neuron, for
example, ankyrin-2 is found in the cell bodies and dendrites, and
ankyrin-3 at the axon initial segments and nodes of Ranvier.
The epidermis is a particularly attractive tissue to investigate the
regulatory mechanisms underlying cell proliferation, differentiation,
and migration. In the epidermis, these processes lead from a basal,
proliferating cell layer to a highly differentiated layer of suprabasal
cells that no longer divide. Whereas the role of keratin intermediate
®laments in epidermis has been investigated in great detail, not the
least due to their involvement in blistering skin disorders (Uitto and
Christiano, 1993; Fuchs and Weber, 1994; Corden and McLean,
1996), the functional signi®cance of the micro®lament system and
its associated proteins is largely unclear. Previous work has
identi®ed an unspeci®ed ankyrin in all layers of human epidermis
(Shimizu et al, 1996).
In order to gain a ®rst insight into the function of ankyrin-3 in
skin, we started to analyze the expression and subcellular
distribution of ankyrin-3 isoforms in mouse skin.
MATERIALS AND METHODS
Southern blot analysis Mouse genomic DNA was isolated according to
Strauss (1994). For southern blot analysis, 10 mg of genomic DNA/lane
were digested with SalI, XbaI, BamHI, EcoRI, HindIII, ClaI, and PstI and
separated on a 0.8% agarose gel. Gels and blots were processed as previously
described (Porter et al, 1996). The hybridization probe was derived from
the membrane-binding domain (positions 1026±1431 of the published
ankyrin-3 sequence (Peters et al, 1995) (Fig 1b) and random prime labeled
(Roche Diagnostics, Mannheim, Germany). Hybridization was performed
under stringent conditions (Magin et al, 1998) with 20 min washes done
three times in 0.1% sodium dodecyl sulfate (SDS)/0.1 3 sodium citrate/
chloride buffer (SSC) at 68°C.
RNA preparation Total RNA of newborn mouse skin and adult mouse
kidney, brain, liver, and heart was isolated with TRIZOL reagent (Gibco
BRL, Karlsruhe, Germany) according to the protocol of the supplier.
Polyadenylated RNA [poly(A)+-RNA] was isolated on Oligo dT Cellulose
columns (Amersham Pharmacia Biotech, Freiburg, Germany).
Northern blot analysis Ten micrograms of poly(A)+-RNA of each
organ was separated on a 0.8% formaldehyde/agarose gel, transferred to a
nylon membrane (Genescreen, DuPont, Germany) and hybridized with a
[32P]-deoxycytidine triphosphate random prime labeled ankyrin-3 probe
derived from the regulatory domain of ankyrin-3 (positions 4781-6012)
(Fig 1b). Final washes were done at 68°C in 0.1 3 SSC/0.1% SDS, then
the blot was subjected to autoradiography at ±80°C. For loading controls,
the blot was reprobed with a mouse glyceraldehyde-3-phosphate
dehydrogenase probe.
For the con®rmation of the new splice variant, the same northern blot
was stripped and reprobed with a riboprobe spanning positions 44 to 122 of
ank-393 (Fig 2). The probe was generated by polymerase chain reaction
(PCR), cloned into a pCR 2.1-Topo vector (Invitrogen, Groningen, The
Netherlands) and in vitro transcribed with T7 RNA polymerase in the
presence of [32P]-labeled rCTP. After hybridization overnight at 65°C, the
blot was washed three times at 72°C in 0.13SSC/0.1% SDS.
Reverse transcription±PCR for the isolation of ankyrin-3
cDNAs For the isolation of ankyrin-3 cDNA clones, we performed
reverse transcription±PCR. Total RNA from mouse skin was prepared as
described above. Primers were deduced upstream of the 5¢-start codon and
downstream of the 3¢-stop codon of a published Ank3-sequence (Peters
et al, 1995) (EMBL/GenBank/DDBJ accession no. L40631): sense primer
(primer 1): 5¢±GATCTCAAGGAAAGATGAGT-3¢ (positions 43±62);
anti-sense primer (primer 4): 5¢±CTGCTGATCTCTGGTGAGTT±3¢
(positions 6012±5993) (Fig 1a). In the reverse transcription reaction, 1 mg
of total RNA and 20 pmol of hexanucleotide primers (Roche) were
incubated at 85°C for 1 min, followed by a 10 min incubation at 65°C.
After a short incubation on ice, 10 mM dithiothreitol, 1 mM
deoxyribonucleoside triphosphate (sodium salts), 20 units RNAsin
(Promega, Mannheim, Germany), and 50 units of ExpandÔ Reverse
Transcriptase (Roche) were added to reach a total volume of 20 ml. The
reaction was incubated for 10 min at 30°C, 45 min at 42°C and then
stopped on ice. Immediately after reverse transcription, PCR was
performed with the Expand Long Template PCR-System (Roche) in a
50 ml reaction mixture with buffer 3, containing 5 ml of template cDNA,
0.5 mM deoxyribonucleoside triphosphate 0.4 mM of each primer, 8%
dimethylsulfoxide and 2.5 units of Expand Long Template enzyme
mixture. Ampli®cation was carried out according to the supplier's
protocol using an annealing temperature of 50°C. Reaction products
were subcloned into the pCRII-Topo vector (Invitrogen) and analyzed by
restriction with several enzymes. For automated DNA sequencing (ABI
prism; PE Biosystems, Weiterstadt, Germany), DNA was puri®ed by
phenol/chloroform, followed by ethanol precipitation and a ®nal wash in
70% ethanol.
Con®rmation of novel isoform by reverse transcription±PCR For
the con®rmation of the small isoform we used two primer pairs: primer 1
(sense primer), positions 43±62; primer 2 (anti-sense primer), positions
3089±3076; primer 3 (anti-sense primer), positions 4992±4971 (Fig 1a).
PCR conditions were as described above. The product of the reverse
transcription±PCR with primers 1 and 2 was sequenced to con®rm the
splice consensus sequence.
Preparation of an ankyrin-3 anti-serum A domain-speci®c ankyrin-3
anti-serum, named ank-3/a, was raised against the sequence
EEEGSTRSEPKQGE of the regulatory domain (amino acid positions
1930±1943) (Fig 1c) (Eurogentec, Herstal, Belgium). An additional
anti-serum, named ank-3/b, was raised against the peptide
RKRKGKKHLTFTRE, which corresponds to the new splice site
described here for ank-393 (amino acid positions 15±28). The peptides
were coupled to KLH (key limpet hemocyanin) and each were injected
into two rabbits. The ankyrin-3 anti-serum was af®nity puri®ed on the
appropriate peptide. Preimmunsera stainings were negative in western
blotting and immuno¯uorescence analysis.
In vitro transcription/translation In vitro transcription and translation
was performed with the TNT Quick Coupled Transcription/Translation
System (Promega, Heidelberg, Germany) according to the manufacturer's
protocol with biotin-labeled lysine-tRNA (Transcend tRNA). One
microgram of the pCRII-Topo vector containing the cDNA for the
new splice variant was used, and the reaction was incubated for 90 minutes
at 30°C. Two microliters of the lysat were mixed with 20 ml of 1 3 SDS
sample buffer and boiled for 2 min at 95°C. Ten microliters of the sample
were loaded on a 10% SDS±polyacrylamide gel. After the run, proteins
were electrotransferred to a polyvinylidene di¯uoride membrane (Schroder
et al, 1999). For detection of the in vitro translated proteins, the membrane
was blocked in Tris-buffered saline/0.1% Tween-20 for 30 min, followed
by the incubation with Streptavidin±horseradish peroxidase in a 1 : 30,000
dilution for 1 h. For detection, we used Pierce Super Signal Ultra (KMF, St
Augustin, Germany). Alternatively, unlabeled translation products were
detected by western blotting (see below).
SDS±polyacrylamide gel electrophoresis and western blot Total
proteins were extracted from neonatal mouse skin, dermis, epidermis, and
mouse keratinocytes in 1 3 SDS sample buffer (Schroder et al, 1999).
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Dermis and epidermis were separated by incubating decapitated neonatal
mice in water at 60°C for 40 s. Gel electrophoresis was performed by
standard procedures. The proteins were electrotransferred to
polyvinylidene di¯uoride membranes as described above. Membranes
were blocked in 0.1% Tween-20 according to Porter et al, (1996). The
ank-3/a anti-serum was used in a dilution of 1 : 5000, the ank-3/b
antiserum in a dilution of 1 : 2500. For the competition experiment 30 mg
per ml of ank-3/b peptide were added to the primary antibody incubation.
For detection, we used a horseradish peroxidase-conjugated rabbit anti-
mouse anti-serum in a 1 : 30,000 dilution.
Keratinocyte cell culture Primary mouse keratinocytes from wild-type
mice were received from David Melton (Edinburgh, personal
communication). For immuno¯uorescence studies, cells were cultivated
as reported elsewhere (Melton et al, in preparation). Twenty-four hours
before ®xation, the calcium ion concentration was raised to 2 mM.
Immuno¯uorescence microscopy Back skin was taken from
newborn mice, frozen in liquid nitrogen, and stored at ±80°C.
Cryosectioning was performed at ±20°C. Slides were air dried for 2 h
and then ®xed for 10 min at ±20°C in acetone and air dried. Sections were
encircled with a wax pen (Dako, Hamburg, Germany). For ankyrin and
desmoplakin staining, mouse keratinocytes were washed two times in
prewarmed (37°C) phosphate-buffered saline and then ®xed for 3 min
(10 min) in methanol (±20°C), followed by 20 s in acetone (±20°C). For
actin staining, cells were ®xed for 10 min in 4% paraformaldehyde (room
temperature), washed in phosphate-buffered saline and incubated in
acetone (±20°C) for 3±5 min. Primary antibodies ank-3/a and ank-3/b
were used in a dilution of 1 : 100. After incubation in a humidi®ed chamber
for 1 h, the slides were washed three times in phosphate-buffered saline (pH
7.4) and then incubated for 30 min with 25 ml of the secondary antibody
(Alexa-conjugated anti-sera, 1 : 400 dilution, Molecular Probes, Leiden,
The Netherlands) or phalloidin-actin 1 : 40 (Molecular Probes). The
washing was repeated as described, followed by brief rinses in water and
ethanol. Coverslips were mounted with Mowiol containing 5% Dabco
(Calbiochem, Bad Soden, Germany). Tissue sections and keratinocytes
were analyzed with a ¯uorescence photomicroscope (Axiophot2, Zeiss,
Oberkochen, Germany).
Analysis of DNA sequence data The analysis of the DNA and protein
sequences was performed using the Heidelberg Unix Sequence Analysis
Resources (HUSAR) program based on the Genetics Computer Group
(GCG) programs.
RESULTS
cDNA cloning of ankyrin-3 from mouse skin So far, most
ankyrin-3 splice variants have been analyzed in single layered
epithelia. Based on cross-reacting anti-sera and RNA hybridization
data, previous work has hinted towards the presence of an
unspeci®ed ankyrin in epidermis (Peters et al, 1995; Shimizu et al,
1996). In order to investigate the role of ankyrin-3 in skin, we
initiated the cDNA cloning of ankyrin-3 from total RNA isolated
from newborn mouse skin. Based on primers deduced upstream of
the start codon, and downstream of the stop codon of an ankyrin-3
cDNA from mouse kidney epithelium (Peters et al, 1995), we
performed reverse transcription±PCR optimized for long
trranscripts (Fig 1). This led to the isolation of three ankyrin-3
cDNAs from mouse skin RNA.
The largest cDNA clone (5766 bases, counted from the start to
stop codon) exhibited 99.1% identity (18 exchanges, of which one
is conservative) by sequence comparison with the published 7 kb
isoform in the kidney. Inserts A and B, typical of kidney ankyrin-3
were lacking (Fig 3). The size difference between the isolated
clone and the published 7 kb isoform results from the 5¢ and 3¢
untranslated regions, which are not isolated by our reverse
transcription±PCR approach. These add approximately 1.2 kb to
each of the cDNAs.
The second cDNA clone (5244 bases) corresponded to another
splice variant of the 7 kb clone exhibiting 99.3% sequence identity
with 14 exchanges of which one is conservative. It also codes for
insert A, but lacks the acidic insert C in the regulatory domain. In
both clones, amino acid 115 in the third ankyrin repat is
exchanged, but replaced by different amino acids. At present, we
cannot decide whether this is due to a polymorphism or an error in
one of the sequences.
The smallest ankyrin-3 cDNA encoded an open reading frame of
2517 bases and represents a novel isoform with unique features
(Figs 2 and 3). The ®rst 21 amino acids of the N-terminal
membrane-binding domain were identical to those of ankyrin-3 in
the kidney, but the typical ankyrin repeats were absent. In addition,
the ®rst 75 amino acids of the N-terminal part of the spectrin-
binding domain were missing, resulting from a splice pattern that
has not been reported before. Starting from amino acid position 22,
the cDNA was identical to the published 7 kb ankyrin-3 isoform
starting at position 949 and missing insert C. Only one difference to
the published ankyrin-3 sequence was found: amino acid residue 81
of the new splice variant was changed from isoleucine to valine.
The ankyrin encoded by this cDNA, which we named ank-393,
represents a new splice variant.
The HUSAR program PEPSTATS predicted a protein of 838
amino acids with a predicted mass of 93 kDa and a calculated
isoelectric point of 8.32 for ank-393. This protein was detected in
western blotting after coupled in vitro transcription/translation of
Figure 2. Protein structure of the ankyrin-3 splice variants isolated
from mouse skin. The splice pattern of clone 1 and clone 2 is identical to
the one described for ankyrin-3 isoforms detected in mouse kidney: (with
inserts (A) cross-stiped, (B) black, and (C ) vertically striped (Peters et al,
1995). Clone 3 exhibits a new splice pattern lacking not only all ANK
repeats, but in addition the N-terminal part of the spectrin-binding domain
(dotted).
Figure 1. Analysis of ankyrin-3 expression in mouse skin. (A) Primers
deduced for reverse transcription±PCR based on the 7 kb ankyrin-3
isoform mRNA detected in the mouse kidney (Peters et al, 1995). Primers 1
and 4 were used for the isolation of complete ankyrin-3 cDNA clones.
Primers 2 and 3 were used in combination with primer 1 for a reverse
transcription±PCR to con®rm the existence of the isolated 2.5 kb isoform.
(B) Hybridization probes used in southern (S) and northern (N) blotting.
(C ) Localization of the epitope used for the ank-3/a anti-serum synthesis.
For exact nucleotide positions see Materials and Methods.
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the corresponding cDNA both by streptavidin±horseradish perox-
idase and the newly synthezised ank-393 anti-serum (see below).
The protein migrated at about 98 kDa (Fig 4). In addition, two-
dimensional gel electrophoresis of the in vitro translated protein
con®rmed its calculated isoelectric point (8.32) (data not shown). In
order to test whether ankyrin-3 isoforms, including ank-393, were
the products of a single gene, we performed southern blot analysis
(Fig 5). Mouse genomic DNA was digested with several restriction
enzymes and hybridized with a probe corresponding to ANK
repeats 9±14 of the membrane-binding domain of ankyrin-3.
Under stringent conditions only one fragment of each restriction
digest was recognized, indicating that all ankyrin-3 splice forms
were the products of a single copy gene.
Con®rmation of the new splice variant In order to get
additional evidence for the presence of the mRNA for ank-393, we
designed a reverse transcriptase±PCR experiment that would detect
our novel splice variant. The positions of the two primer pairs are
outlined in Fig 1. The ampli®ed products should have a length of
267 bases (primers 1/2) and 2122 bases (primers 1/3), respectively,
to be speci®c for the new isoform. In two separate approaches, we
were able to amplify the expected fragments reproducibly (Fig 6b).
Beside the two expected fragments, a 600 bp fragment was
ampli®ed, indicating an additional ankyrin-3 isoform that has not
been characterized further by cDNA cloning. Sequencing of the
ampli®ed 267 bases product con®rmed the splice pattern of the
complete 2.5 kb clone.
Tissue-speci®c expression of ankyrin-3 Next, we used a
probe derived from the regulatory domain of ankyrin-3, which
does not cross-react with ankyrin-1 or ankyrin-2 to study the
expression of all ankyrin-3 splice variants. In mouse skin, mRNA
of 8.6, 7.0, 6.4, 5.2, 4.5, and 3.7 kb were detected (Fig 7a). Of
these, the 7.0 and the 6.4 kb mRNA correspond to those
Figure 3. Nucleotide and deduced amino acid
sequence of the novel ankyrin-3 splice var-
iant ank-393. The start of each domain is marked
by an arrow. Compared with the 7 kb ankyrin-3
isoform described in kidney the 24 ANK repeats
and the ®rst 75 amino acids of the spectrin-bind-
ing domain, all together a 2.8 kb insert, are absent.
The hybridization probe used in northern blotting
for the con®rmation of ank-393 is underlined. The
epitope used for synthesis of the ank-393 antiserum
is underlined. These sequence data are available
from EMBL/GenBank/DDBJ under accession
number AF212924.
Figure 4. Ank-393 encodes a protein of about 98 kDa. Clone 3 was
translated in vitro with a biotin-coupled amino acid and after electrophoresis
analyzed. The new ank-393 anti-serum and streptavidin±horseradish
peroxidase both gave a single strong signal of about 98 kDa. Lane 1:
Coomassie staining of in vitro translated protein; lane 2: negative control (no
plasmid); lane 3: detection with ank-3/b; Lane 4: detection with
streptavidin±horseradish peroxidase. On the left side, the protein marker
sizes are denoted.
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previously reported in kidney epithelium (Peters et al, 1995) and
cloned in this report. These mRNA give rise to ankyrin isoforms of
214 and 190 kDA (for western blotting, see below). In addition to
mRNA identi®ed by cDNA cloning, our northern blot data
predict at least three additional ankyrin-3 isoforms in mouse skin.
As ankyrins are widely expressed in most tissues, northern blot
analysis was extended to mouse kidney, brain, heart, and liver (Fig
7a). This revealed the prevalance of splice variants of about 5 kb in
skin, but also in liver. In contrast, large isoforms of ankyrin-3 are
the major mRNA in brain and heart: isoforms of more than 10 kb
dominate in brain, isoforms of about 7 kb in heart. Smaller isoforms
could only be detected in minor amounts. Only in kidney,
prominent mRNA of about 4±5 kb and 6±7 kb were seen with
additional minor mRNA ranging from 3 to 9 kb.
In order to detect the mRNA for ank-393 selectively by northern
blotting, we used a riboprobe covering 40 bases upstream and 40
bases downstream of the potential new splice site (Fig 2). Given
that ank-3 mRNA contains 5¢- and 3¢-untranslated regions of
1.2 kb, we predicted a mRNA of 3.7 kb for the newly discovered
ank-393. In addition, this probe should detect potential additional
isoforms exhibiting the same splice pattern. This riboprobe was ®rst
characterized on in vitro transcribed RNA of the 5.8 kb and 2.5 kb
cDNA and proved to be speci®c for the new splice variant (data not
shown). When the tissue northern blot (Fig 7a) was reprobed with
this riboprobe (Fig 7b), we detected a single mRNA of 3.7 kb
exclusively in mouse skin. Therefore, we conclude that the ank-393
splice variant is skin speci®c.
In order to correlate mRNA and protein expression, we raised
an anti-serum against ankyrin-3 (named ank-3/a) based on the
results of the sequencing of our cDNA clones. This anti-serum was
supposed to recognize all published ankyrin-3 isoforms. The
peptide was derived from the C-terminus of the regulatory domain
(Fig 1). The af®nity puri®ed anti-serum ank-3/a was used in
western blotting of total protein extracts of mouse skin, mouse
dermis, epidermis, and mouse keratinocytes (Fig 8). Among
multiple proteins, polypeptides of 214, 190, and 93 kDa were
detected in mouse skin, corresponding to the proteins predicted by
cDNA cloning and northern blotting. Ank-393 appeared only as a
minor product. Therefore, the results of the Western blotting were
in agreement with the results of our northern blot experiment and
strongly suggest the presence of ank-393 in mouse skin.
Localization of ankyrin-3 in mouse skin We analyzed the
localization of ankyrin-3 in mouse skin by immuno¯uorescence
with the ank-3/a anti-serum. The anti-serum should detect all
ankyrin-3 isoforms containing the C-terminal part of the regulatory
domain, which includes all ankyrin-3 isoforms presently known.
All living layers of the epidermis in neonatal mouse skin showed
an intense ankyrin-3 staining (Fig 9). In the basal layer of
epidermis, including the hair follicles the most intense ¯uorescence
was observed. Ankyrin was detected in zones of cell±cell as well as
of cell±matrix contact. Beside the prominent staining at the plasma
membrane, a light punctate staining was seen in the cytoplasm. The
stratum corneum was not stained. A similar distribution was noted
in human epidermis (data not shown).
Localization of ankyrin-3 and ank-393 in mouse
keratinocytes For the better evaluation of the intracellular
localization of ankyrin-3, we performed immunostaining of
ankyrin-3 in primary mouse keratinocytes (Fig 10). Staining with
ank-3/a revealed that ankyrin-3 was distributed almost evenly over
the complete cytoplasm with a slight increase in ¯uorescence
intensity in the nuclear perimeter (Fig 10a). No signi®cant
codistribution with actin could be found (data not shown).
Staining with the ank-3/b anti-serum revealed a vesicular
distribution of ank-393 (Fig 10b), which was not identical to the
Golgi apparatus (data not shown). In addition, there was a weak but
Figure 5. Ankyrin-3 is the product of a single copy gene. Southern
blot of mouse genomic DNA. Restrictions were as follows: SalI (1), XbaI
(2), BamHI (3), EcoRI (4), HindIII (5), ClaI (6), and PstI (7). The
hybridization probe, corresponding to the ANK repeats 9±14 of the
membrane-binding domain, recognized a single fragment of each
restriction digest, indicating ankyrin-3 splice variants to be the product
of a single copy gene.
Figure 6. The splice consensus of ank-393 is con®rmed by reverse
transcription±PCR. With two primer pairs (primers 1 and 2, primers 1
and 3) we analyzed for the presence of the mRNA coding for the small
isoform in total RNA of mouse epidermis. (a) Position of the primers and
size of the expected products. The PCR should generate one fragment of
267 bases (primer pair 1/2) and one of 2122 bases (primer pair 1/3) (for
exact primer positions see Materials and Methods). (b) Gel electrophoresis of
reverse transcription±PCR products, which correspond to the expected
sizes. Lane 1: DNA size marker (100 bp ladder); lane 2: PCR with primer
pair 1/2; lane 3L PCR with primer pair 1/3; lane 4: negative control with
total RNA; lane 5: negative control without mRNA. Moreover, a 600 base
fragment was ampli®ed, indicating an additional ankyrin-3 splice variant
not isolated by reverse transcription±PCR.
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distinct staining along the plasma membrane that did not colocalize
with desmoplakin (data not shown). When cells were ®xed brie¯y,
a strong staining was observed in the nucleus. Upon prolonged
®xation, the nuclear staining disappeared, as reported for the
armadillo family (e.g., Mertens et al, 1996) (Fig 10b inset).
In conclusion, we have identi®ed a novel skin-speci®c ankyrin-3
isoform, which represents the ®rst ankyrin lacking all ANK repeats
and the N-terminal part of the spectrin-binding domain. It is
expressed in mouse skin together with at least two other ank-3
splice variants. Future studies will address the function of ank-393,
which represents the ®rst skin-speci®c ankyrin.
DISCUSSION
In order to gain an insight into the molecular organization and
distribution of ankyrin-3 in epidermis, we have started its analysis in
mouse skin. In this study, we describe the cDNA cloning of
ankyrin-3 splice variants from mouse skin. Most importantly, we
have isolated a novel skin-speci®c ankyrin-3 isoform, ank-393,
which results from a new splice pattern that has not been described
before. Using a cRNA probe and a newly generated anti-serum
that speci®cally reacted with ank-393, we have demonstrated that
ank-393 is expressed exclusively in mouse skin. Here, the
immuno¯uorescence analysis indicated a predominant localization
along the basolateral membranes of the basal epidermal layer. In
addition, all living strata of mouse epidermis were labeled
throughout the cytoplasm. A similar pattern was observed in
primary mouse keratinocytes grown in the presence of elevated
Ca2+ ion levels. Most notably, ank-393 was also localized in distinct
nuclear patches, providing appropriate ®xation conditions. Such a
dual localization has by now been reported for a number of
proteins, including members of the armadillo family (Hatzfeld,
1999). Given that ank-393 lacks part of the spectrin-binding domain
and all of its ANK repeats, we suggest that a dual localization would
be compatible with its domain structure. Whether ank-393
performs functions diferent from known ankyrins, will be analyzed
in the future.
The main difference between ankyrin-3 isoforms is the presence
or absence of part or all of the membrane-binding repeat domain.
Whereas large ankyrin isoforms typically are located underneath the
plasma membrane, small isoforms lacking the repeat domain seem
to localize at other membranes inside the cell (Devarajan et al, 1996;
Hoock et al, 1997). This is an important observation, as the
complete sequence of ankyrin-3 splice variants is contained within
the full-length ankyrin-3, which is located under the plasma
membrane. The mechanism responsible for the exclusion of large
isoforms from intracellular membranes is not known. Potential
mechanisms could involve phosphorylation of ankyrin, association
with other proteins, or maybe a speci®c subcellular localization
during the biosynthesis of ankyrins. Our analysis of the ankyrin-3
expression in mouse skin revealed for the ®rst time, that in skin,
like in other tissues, a multitude of ankyrin splice variants exists. In
this study, we report on three ankyrin-3 isoforms. Based on their
domain structure and known sequence we predict that the two
large isoforms, ank-3214 and ank-3190 are localized at the plasma
membrane, as they contain the full-length membrane-binding
domain with all ANK repeats. The third isoform, which we termed
ank-393, has a unique domain structure: it lacks all ANK repeats
and 75 amino acids of the N-terminal part of the spectrin-binding
domain. It was shown that the N-terminal 70 amino acids of the
spectrin-binding domain of ankyrin-1 are most important for the
regulation of the spectrin-binding af®nity and the distinctive
cellular localization of ankyrin. This unique N-terminal subdomain
of the spectrin-binding domain has been suggested to regulate the
Figure 7. Ankyrin-3 is expressed in multiple splice variants in
several mouse tissues. (a) Expression of ankyrin-3 in mouse tissues: skin
(1), kidney (2), brain (3), heart (4), and liver (5). The mRNA of ankyrin-3
splice variants was analyzed by hybridization with a cDNA encoding part of
the regulatory domain of ankyrin-3. The amount of RNA loaded in each
lane was controlled by hybridization with mouse glyceraldehyde-3-
phosphate dehydrogerase cDNA. mRNA sizes were estimated relative to
16S and 23S ribosomal RNA. The sizes of the mRNAs detected in mouse
skin are denoted on the left side of the panel (b). Detection of the 3.7 kb
mRNA encoding the new ankyrin splice variant ank-393 exclusively in
mouse skin, after rehybridization of the same northern blot with a splice
variant speci®c riboprobe.
Figure 8. Multiple isoforms of ankyrin-3 can be detected in mouse
skin on the protein level. (a) Immunoblot analysis of ankyrin-3 in mouse
skin (lane 1), dermis (lane 2), epidermis (lane 3), and keratinocytes (lane 4).
Total protein extracts were immunoblotted and incubated with ankyrin-3
anti-serum directed against the regulatory domain. On the left side, the
protein marker sizes are denoted. (b) Mouse skin protein extract was
incubated without (lane 5) and in the presence of the peptide used for
immunization (lane 6) to test the speci®city of the ank-3/b serum. In the
presence of the competitor, the signal was absent. On the left side, the
protein marker sizes are denoted.
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speci®c af®nities of ankyrin family members to spectrin (Platt et al,
1993). As this domain is missing in ank-393, the spectrin af®nity
probably is either no longer modulated, or different ankyrin
domains are required for this function. As we have shown by
northern and western blot analysis, it is a skin-speci®c isoform of
minor abundance, but the functional signi®cance of the protein
remains to be clari®ed. In mouse keratinocytes, we found a
vesicular distribution of ank-393. Several small isoforms of ankyrin
have been described to localize at the Golgi apparatus, but no
colocalization could be detected in immuno¯uorescence staining
with a Golgi marker.
Ankyrin as a binding partner for integral membrane proteins and
the spectrin-based cytoskeleton is believed to be a key player in the
polarization of cells and in keeping up the integrity of specialized
membrane domains (Kunimoto et al, 1991; Otto et al, 1991; Kordeli
et al, 1995). Of note, ankyrin is a binding partner for transmem-
brane channels and was shown to be a binding partner for the
amiloride-sensitive sodium-channel in renal epithelium (Smith et al,
1991). Recently, it was demonstrated that amiloride-sensitive
epithelial sodium channels are upregulated in epidermal develop-
ment (Oda et al, 1999). These channels might play an important
part in epidermal differentiation and skin development possibly by
modulating the ion transport required for the epidermal terminal
differentiation. This process might be regulated by the association
to ankyrins. A development-dependent expression of ankyrin
isoforms has also been observed on brain-speci®c ankyrin splice
variants (Kunimoto et al, 1991; Otto et al, 1991). In analogy to
brain, there are also numerous ankyrin isoforms in skin. In
agreement with cDNA sequencing and our immunohistochemical
data, membrane-bound as well as cytoplasmic ankyrins were found.
Among known ankyrin-binding partners, spectrin is the best
characterized. It binds to ankyrin via the 15th repeat of b-spectrin.
In normal human epidermis and in keratinocytes, a-spectrin has
been found localized in the cytoplasm and associated with the
plasma membrane (Mutha et al, 1991). Interestingly, in cutaneous
tumors membrane-bound spectrin was diminished or lacked
completely depending on the increase of depolarization and
proliferation of tumor cells, and in some cases, the cytoplasmic
spectrin staining was increased instead (Tuominen et al, 1996).
So far, there is no in vivo evidence for the function of ankyrin-3
in epidermis. Based on the results of ankyrin-2 knockout mice
(Scotland et al, 1998) it has been postulated, that ankyrin-2 might
contribute to the increased mechanical stability of brain tissue by
binding to a transmembrane protein (L1), and the intracellular
actin±spectrin network. This interaction, which might involve
additional proteins, could represent a transcellular actin-based
cytoskeleton. Such an array would be analogous to the keratin±
desmosome skeleton, which builds the architectural framework for
Figure 9. Ankyrin-3 is localized predominantly in all living layers of
the epidermis and hair follicles of mouse skin. (a) Immuno¯uores-
cence analysis of neonatal mouse skin with the ank-3/a anti-serum revealed
an intense membrane bound ¯uorescence and a diffuse but punctate
cytoplasmic staining in all living layers of the epidermis, including the hair
follicles; scale bar: 18 mm. (b) At higher magni®cation, the predominant
localization in the cell-cell and cell±matrix contact zones of the basal layer
become visible; scale bar: 11 mm.
Figure 10. Ankyrin-3 localization in mouse primary keratinocytes.
(a) Immuno¯uorescence analysis revealed that ankyrin-3 was distributed
almost evenly over the complete cytoplasm. Note the slight increase in
¯uorescence intensity in the nuclear perimeter (ank-3/a anti-serum). (b)
Ank-393 exhibited a vesicular distribution in the cell (ank-3/b anti-serum)
with a weak but distinct staining along the plasma membrane (arrowheads).
After prolonged ®xation, the staining in the nucleus disappeared (inset).
Scale bar: 18 mm.
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the coherence of epithelial cells. In the light of blistering skin
disorders resulting from keratin mutations it will be important to
characterize further the function of ankyrin in epidermis.
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